| Compass Behavioral Health | |
|
531 Campus View St Garden City KS 67846-7904 | |
| (620) 275-0644 | |
| (620) 272-0239 |
| Full Name | Compass Behavioral Health |
|---|---|
| Speciality | Clinic/Center |
| Location | 531 Campus View St, Garden City, Kansas |
| Authorized Official Name and Position | Lisa Southern (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 6202750644 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Compass Behavioral Health Po Box 1905 Garden City KS 67846-1905 Ph: (620) 275-0644 | Compass Behavioral Health 531 Campus View St Garden City KS 67846-7904 Ph: (620) 275-0644 |
| NPI Number | 1922058510 |
|---|---|
| Provider Enumeration Date | 05/12/2006 |
| Last Update Date | 05/17/2023 |
| Certification Date | 05/17/2023 |
| Medicare PECOS PAC ID | 1355323122 |
|---|---|
| Medicare Enrollment ID | O20040604000376 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922058510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | STATE OF KANSAS 001 (Kansas) | Primary |
| Provider Name | Tracy Lynn Davies |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033134143 PECOS PAC ID: 4880639293 Enrollment ID: I20050627000504 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Michael J Southern |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1265622864 PECOS PAC ID: 6709968449 Enrollment ID: I20080202000015 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Christine A Guebara |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578513164 PECOS PAC ID: 9739371493 Enrollment ID: I20101013000444 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Carol J Lightner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1760432322 PECOS PAC ID: 7315130481 Enrollment ID: I20101021000330 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Danielle B Henson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1316160427 PECOS PAC ID: 1355465774 Enrollment ID: I20150721001234 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Leslie A Goertzen |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1558626622 PECOS PAC ID: 9537466347 Enrollment ID: I20160322001908 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Megan D Garcia |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1740569342 PECOS PAC ID: 4082903505 Enrollment ID: I20160523000675 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Brent A. Crane |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1336469287 PECOS PAC ID: 9739336058 Enrollment ID: I20170802000896 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Shivanna V Kumar |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1326147992 PECOS PAC ID: 1254684244 Enrollment ID: I20181020000542 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Donna R Julian |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1366793747 PECOS PAC ID: 5597042168 Enrollment ID: I20200513002081 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Chelsea Gray |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801411731 PECOS PAC ID: 1153734173 Enrollment ID: I20210113000524 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Janese S Boger |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831350388 PECOS PAC ID: 8022423151 Enrollment ID: I20210223000328 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Cameron Brown |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548998859 PECOS PAC ID: 6204212590 Enrollment ID: I20221011001225 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Jeremy Estell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164143335 PECOS PAC ID: 5890161863 Enrollment ID: I20221015000220 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Tanya Tavares |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1598397069 PECOS PAC ID: 6305294000 Enrollment ID: I20231117002654 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Maria C Cooper |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1134610900 PECOS PAC ID: 0941658116 Enrollment ID: I20231128003587 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Brooke Cooper |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1023575073 PECOS PAC ID: 1355799370 Enrollment ID: I20231130001902 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
| Provider Name | Kathleen Warner-long |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1881710879 PECOS PAC ID: 9436508173 Enrollment ID: I20231207000434 |
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
News Archive
NPR's "Shots" blog reports on efforts to eradicate polio in Nigeria. "[N]orthern Nigeria is the only place in the world where polio cases are increasing," the blog writes, noting, "As of Sept. 1, it had recorded 90 polio cases in 2012 - or nearly three times as many as in the same period last year."
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.
› Verified 1 days ago
Area Mental Health Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1111 E Spruce St, Garden City, KS 67846 Phone: 620-276-7689 Fax: 620-276-6117 | |
In His Image Christian Counseling, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 201 E Laurel St, Garden City, KS 67846 Phone: 620-272-9506 Fax: 620-272-9833 | |
Compassionate Counseling Services, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1807 E Mary St Ste 6, Garden City, KS 67846 Phone: 785-477-0188 | |
United Methodist Mexican American Ministries Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 122 W. Laurel Street, Garden City, KS 67846 Phone: 620-271-7400 Fax: 620-860-2131 | |
Healing Steps Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1804 E Laurel St, Garden City, KS 67846 Phone: 620-277-9338 | |
Area Mental Health Center Physicians Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1111 E Spruce St, Garden City, KS 67846 Phone: 620-276-7689 Fax: 620-276-6117 | |
St Catherine Hospital Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 Fax: 620-272-2755 |